Prostaglandin E2 (PGE 2 ) plays a critical role in intestinal mucosal tolerance and barrier integrity. Cyclooxygenase-2 (COX-2)-dependent PGE 2 production involves mobilisation of arachidonic acid. Lactobacillus rhamnosus GG (LbGG) is one of the most widely used probiotics reported to colonise the colonic mucosa. LbGG contributes to the protection of the small intestine against radiation injury through the repositioning of mucosal COX-2 expressing cells. However, it is unknown if LbGG modulates PGE 2 production in the colonic mucosa under homeostasis and the major cellular elements involved in these processes. Colonic epithelial and
of myeloid differentiation factor-88 expression in CMFs abrogated LbGG-induced upregulation of COX-2 in culture and in vivo. Taken together, our data suggest that LbGG increases release of COX-2-mediated PGE 2 , contributing to the maintenance of mucosal homeostasis in the colon and CMFs are among the major contributors to this process.
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lactic acid bacteria, mechanism of action, metabolic processes, microbial cell interaction, COX-2 1 | INTRODUCTION Prostaglandins (PGs) are important lipid mediators that regulate numerous physiological and pathophysiological processes in the gut (Fujii et al., 2016) . During homeostasis, PGs have a protective role in the gastrointestinal (GI) mucosa and are critical to the maintenance of mucosal epithelial barrier integrity (Morteau, 2000) . Prostaglandin E2 (PGE 2 ) is involved in the regulation of vascular permeability and promotion of epithelial cell proliferation (Eberhart & Dubois, 1995; Stenson, 2014) . PGE 2 is also required for the suppression of acute colitis and protection against mucosal damage (Jiang et al., 2006; Miyoshi et al., 2017) .
Despite its beneficial effects, inducible PGE 2 also contributes to chronic inflammation and cancer. During inflammatory bowel disease, high levels of PGE 2 exacerbate the inflammatory processes (Morteau, 2000; Sheibanie et al., 2007) . Therefore, there is a dichotomy in PGE 2 -mediated action: Although this molecule contributes to the chronicity of GI inflammatory responses and cancerogenesis, it is also critical to gut mucosal homeostasis.
The initial step in the biosynthesis of inducible PGs results from the liberation of arachidonic acid (AA) from membrane glycerophospholipids by phospholipase A 2 (PLA 2 ). Released AA is metabolised into PG G 2 and then to PGH 2 by two major cyclooxygenase (COX) isoforms, COX-1 or COX-2 (Smith, Urade, & Jakobsson, 2011) . PGH 2 is finally converted by cell-and tissue-specific prostanoid synthases to various bioactive PGs, particularly PGE 2 (Kudo & Murakami, 2005) . COX-1 is constitutively expressed to maintain normal housekeeping functions, whereas COX-2 is known to be induced in response to GI inflammation and injury (Iyer, Srivastava, Dev, Dastidar, & Ray, 2009; Smith, Garavito, & DeWitt, 1996) .
Several intestinal mucosal cells are reported to produce COX-2-dependent PGE 2 during injury, inflammation, and cancer (Fukata et al., 2006) . In contrast, cells of mesenchymal origin are known to produce PGE 2 , not only during inflammation and cancer but also in GI homeostasis (Powell, Pinchuk, Saada, Chen, & Mifflin, 2011; Reisinger et al., 2017; Zhu, Hua, & Lance, 2003) . Among such cells, colonic CD90 + (myo) fibroblasts (CMFs) are abundant innate immune cells in the normal GI mucosa that have recently emerged as key contributors to GI mucosal homeostasis (Beswick et al., 2014; Pinchuk et al., 2011; Pinchuk, Mifflin, Saada, & Powell, 2010; Powell et al., 2011) . Following epithelial injury, intestinal (myo) fibroblasts are reported to sense inflammatory signals and activate COX-2-dependent PGE 2 production, contributing to the regeneration of the epithelium (Roulis et al., 2014) . Repositioning of COX-2-expressing mesenchymal stem cells (MSC)-like cells in the intestinal mucosa has been shown to have a radioprotective effect and contribute to wound healing (Brown et al., 2007; Riehl, Foster, & Stenson, 2012) .
The GI tract, and in particular the colon, is highly populated by the microbiota, which is important to the maintenance of homeostasis.
The microbiota also strongly influences immune responses to injury, justifying current interest in microbiota-based probiotic therapies for several GI pathologies (Scaldaferri et al., 2013) . However, little is known about how COX-2/PGE 2 is regulated by the normal gut microbiota under homeostasis. The effect of probiotics on the regulation of inducible PGE 2 has been mostly studied in culture using cancer cell lines (Otte et al., 2009; Simeoli et al., 2015) .
Lactobacillus rhamnosus GG (LbGG) is one of the most widely used probiotic strains. It demonstrates potent immunomodulatory activity and is able to at least temporarily colonise the human colonic mucosa (Segers & Lebeer, 2014) . LbGG has been reported to induce COX-2 protein expression in T84 colonic epithelial cancer cell lines (Korhonen, Kosonen, Korpela, & Moilanen, 2004) . It has also been demonstrated that LbGG may enhance healing of gastric ulcers in rats via increased synthesis of PGE 2 (Lam et al., 2007) and contribute to the protection against radiation injury in the small intestine of mice through repositioning of COX-2 expressing cells (Ciorba et al., 2012) . However, how LbGG modulates the COX-2/PGE 2 pathway in the normal colonic mucosa and which cells in the mucosa are the primary site of COX-2 induction by this bacteria remains unknown.
In this study, we tested the hypothesis that under colonic homeostasis, LbGG enhances AA metabolism, expression of COX-2, and PGE 2 secretion in both epithelial and stromal compartments of the colonic mucosa. We observed that among five neoplastic colonic epithelial cell lines exposed to LbGG, only stimulation of Caco-2 resulted in increased expression of components within the overall eicosanoid pathway. Moreover, LbGG stimulated the COX-2/PGE 2 pathway but not the leukotriene pathway in primary human CMFs isolated from the normal colonic mucosa, and this process was myeloid differentiation factor-88 (MyD88)-dependent. Using a murine model, we observed that oral administration of LbGG led to an increase in the both AA and COX-2 in the mouse colonic mucosa. The increase in COX-2 protein expression was seen in the mucosal lamina propria, mostly colocalised with CMFs, and this process depends on MyD88 expression by CMFs. Taken together, our data suggest that, under homeostasis, LbGG is capable of regulating mucosal levels of COX-2-dependent PGE 2 in a MyD88-dependent manner and that stromal
CMFs are implicated in this process.
2 | RESULTS 2.1 | LbGG induces several components of AA pathway in Caco-2 epithelial cell line
The PGE 2 synthesis pathway is initiated by AA release from the cleavage of membrane phospholipids by cPLA 2 . Therefore, we first evaluated the levels of cPLA2 and its downstream product AA in Caco-2 colonic epithelial cell line cultured with LbGG. We observed an increase in cPLA2 protein expression and AA production in response to 24-hr stimulation with LbGG ( Figure 1a-b) . AA is known to be metabolised by two inducible pathways: COX-2-mediated production of PGs and synthesis of leukotrienes through 5-LO (Stenson, 2014 Additionally, HCT116 (ATCC CCL-247™) and SW480 (ATCC CCL-228™) are reported to be low/negative for inducible COX-2 expression (Buecher et al., 2005) . Using WB analysis, we observed that only Caco-2 out of all tested epithelial cell lines responded to LbGG stimulation with the upregulation of COX-2 protein expression ( Figure 2a) and significant upregulation of secreted PGE 2 (Figure 2b ). Further, cell lines from the above experiments that are known to express inducible COX-2, but did not have increased COX-2 protein levels in response to LbGG stimulation, were polarised and subsequently stimulated with LbGG at the apical compartment of the epithelial cell monolayer. This did not result in an increase of COX-2 protein expression at 24 hr after exposure to LbGG (Supporting Information Figure S1 ). Surprisingly, stimulation of the Caco-2 epithelial cell line, which did show upregulation of COX-2 with LbGG, did not demonstrate a significant change in COX-2 mRNA levels (see Supporting Information Figure   FIGURE 1 Lactobacillus rhamnosus GG (LbGG) induces an increase in cPLA2, release of AA, an increase in COX-2 expression, and increased PGE 2 production in Caco-2 cells. Caco-2 cells were exposed to LbGG (10 bacteria: 1 epithelial cell) for 24 hr and harvested for Western blot and ELISA analysis. (a) Western blot using anti-cPLA2 revealed a significant increase in cPLA2 protein expression in Caco-2 cells following exposure to LbGG. Protein density was normalised to the housekeeping protein β-actin (relative density), and adjusted density was calculated for each sample by dividing the relative density of the experimental condition by those obtained for a control sample. 2.3 | LbGG stimulates the increase in COX-2 and PGE 2 within the eicosanoid pathway but not 5-LO in human CMFs
CMFs are located just beneath the epithelial basement membrane and are an abundant cell phenotype in the colonic lamina propria (Saada et al., 2006) . CMFs are known to be the major producers of COX-2-dependent PGE 2 in the colonic mucosa (Mifflin et al., 2002) . Thus, we determined the contribution of CMFs to LbGG-induced PGE 2 synthesis. For this purpose, normal primary human CMF isolates were cocultured with LbGG. We observed that 24-hr treatment with LbGG led to a significant increase in both cPLA2 and COX-2 protein levels in CMFs (Figure 3a -b). In contrast, 5-LO enzyme production is slightly decreased (Figure 3c ). Moreover, CMFs responded to stimulation by
LbGG with an increase in PGE 2 production ( Figure 3d ). These results suggest that LbGG preferentially induced COX-2 and PGE 2 rather than 5-LO-mediated leukotriene synthesis in CMFs.
| LbGG-induced COX-2 upregulation in CMFs is MyD88-dependent
Because LbGG is reported to protect the murine intestinal epithelium from radiation injury through a MyD88/COX-2-dependent mecha- are expressed as means ± SEM. One-way analysis of variance was used to calculate the significance of the obtained results, three experimental repeat per tested cell line were run in duplicate (n = 6), ****p < 0.0001. COX-2: cyclooxygenase-2; LbGG: Lactobacillus rhamnosus GG; PGE 2 : prostaglandin E2 d). Interestingly, the LbGG-induced increase of COX-2 is mostly observed in the mucosal lamina propria, whereas only sparse and an occasional increase in COX-2 expression was seen in the colonic epithelium.
CMFs are a major component of the colonic mucosal lamina propria (Powell et al., 1999; Powell et al., 2011; Saada et al., 2006) . In this work, we highlighted the ability of the probiotic LbGG to induce COX-2-dependent PGE 2 production in the whole colonic mucosa and in subepithelial (myo) fibroblasts through a MyD88-dependent mechanism. Taken together with the previously described functions of PGE 2 in the colonic mucosa, our data suggest that probiotic treatment with LbGG could participate in the maintenance of epithelial barrier integrity and mucosal tolerance through increased release of COX-2-mediated PGE 2 by mucosal (myo) fibroblasts.
Further, the fact that some colon carcinoma epithelial cells can respond to LbGG with tumorigenic PGE 2 secretion suggests that probiotics should be used with caution in patients with known colorectal cancer. 
| Cells
Human colonic epithelial cell lines Caco-2, HT-29, HCT-116, LS-174 T, and SW-480 were purchased from ATCC (Manassas, VA, USA) grown in minimal essential medium culture medium (Gibco, CA, USA) supplemented with 10% fetal calf serum (Sigma), 100 μg/ml streptomycin, 100 U/ml penicillin, 2-mM L-glutamine, and 1-mM non-essential amino acids. For CMF isolation, full thickness fresh human colonic mucosa samples were obtained from discarded surgical resections under University of Texas Medical Branch (UTMB) approved Institutional Review Board (IRB) protocol #99-061. CMFs were isolated from the normal margin of mucosal colonic tissue of patients undergoing colectomy for colon cancer as described previously and routinely used in our laboratory (Saada et al., 2006; Johnson et al., 2016) . The purity of isolated CD90 + CMFs (98-99%) was confirmed by flow cytometry, as previously described (Saada et al., 2006) . Studies were performed with primary CMF isolates at passages 4-10 and cultured as described previously (Saada et al., 2006) .
| Silencing of MyD88 gene in CMFs
Primary human CMFs lacking MyD88 expression were generated in 
| WB analysis
WB analysis were performed as previously described (Saada et al., 2006 4.7 | AA and PGE 2 determination AA production was determined in human cell extracts by gas chromatography as previously described by a method adapted from Lepage and Roy (1986) . Briefly, 10 μl of 10 mg/ml heptadecanoic acid (C17) were added to 10 million cells (pellet) as an internal standard. Lipids were extracted according to the method by Folch, Lees, and Sloane Stanley (1957) Confocal microscopy was performed with a Zeiss LSM510 META laser scanning confocal microscope (Carl Zeiss, Thornwood, NY).
| LbGG in vivo treatment
All experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of Texas Medical
Branch at Galveston. C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). In the colonic mucosa, α-SMA is specifically expressed by MFs. Tamoxifen-inducible MyD88 floxed mice specific to α-SMA + cells were generated in our lab (MF-MyD88 KO). Previously generated Acta2-CreER T mice (Grcevic et al., 2012; Worthley et al., 2015) expressing CreER T under the α-SMA promoter (Acta-2) were crossed with MyD88 fl/fl mice (The Jackson Laboratory).
The presence of the transgenes was controlled as previously described by using standard polymerase chain reaction protocols as previously described (Beswick et al., 2014; Worthley et al., 2015) . Control mice negative for Acta2-Cre but positive for MyD88 fl/fl recombination derived from at least five backcrossing with C57BL/6 animals were used in this study in order to have similar microbiota composition.
Deletion of MyD88 was induced by intraperitoneal (i.p.) injection of tamoxifen (TMX, 0.5 mg/mice for 4 days, total injection volume/ animal is 100 μl). All mice (female, 6-12 weeks of age) were housed under pathogen-free conditions. Three days after the last TMX injection, animals received 5 × 10 8 CFU/dose of lyophilised LbGG in suspension in PBS or PBS only for 5 days. Colonic tissue samples were then harvested for further analysis.
| Statistical analysis
Unless otherwise indicated, the results were expressed as the mean ± SEM of data obtained from at least three independent experiments done with duplicate sets in each experiment. For experiments comparing the results between two groups, Student's t test was used.
If necessary, the Wilcoxon signed-ranks test was used. For multiple group comparison, one-way analysis of variance with post hoc Tukey's honestly significant difference test was used. Values of p < 0.05 were considered statistically significant.
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